Trends in Systemic Glucocorticoid Utilization in the United Kingdom from 1990 to 2019: A Population-Based, Serial Cross-Sectional Analysis

References

• Scadding GK, Durham SR, Mirakian R, et al. BSACI guidelines for the management of rhinosinusitis and nasal polyposis. Clin Exp Allergy. 2008;38(2):260–275. doi:10.1111/j.1365-2222.2007.02889.x
   PubMed Web of Science ®Google Scholar
• Gordon C, Amissah-Arthur MB, Gayed M, et al. The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults. Rheumatology. 2018;57(1):e1–e45. doi:10.1093/rheumatology/kex286
   PubMed Web of Science ®Google Scholar
• Chronic obstructive pulmonary disease in over 16s: diagnosis and management National Institute for Health and Care Excellence (NICE) Guideline (NG115); 2018. Available from: https://www.nice.org.uk/guidance/ng115. Accessed March 8, 2024.
   Google Scholar
• Lamb CA, Kennedy NA, Raine T, et al. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut. 2019;68(Suppl 3):s1–s106. doi:10.1136/gutjnl-2019-318484
   PubMed Web of Science ®Google Scholar
• British guideline on the management of asthma: a national clinical guideline (Scottish Intercollegiate Guidelines Network [SIGN 158] Evidence-based Clinical Guidelines; British Thoracic Society); 2019. Available from: https://www.sign.ac.uk/media/1773/sign158-updated.pdf Accessed March 8, 2024.
   Google Scholar
• Smolen JS, Landewe RBM, Bijlsma JWJ, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Ann Rheum Dis. 2020;79(6):685–699. doi:10.1136/annrheumdis-2019-216655
   PubMed Web of Science ®Google Scholar
• Bleecker ER, Menzies-Gow AN, Price DB, et al. Systematic literature review of systemic corticosteroid use for asthma management. Am J Respir Crit Care Med. 2020;201(3):276–293. doi:10.1164/rccm.201904-0903SO
   PubMed Web of Science ®Google Scholar
• Volmer T, Effenberger T, Trautner C, Buhl R. Consequences of long-term oral corticosteroid therapy and its side-effects in severe asthma in adults: a focused review of the impact data in the literature. Eur Respir J. 2018;52(4):1800703. doi:10.1183/13993003.00703-2018
   PubMed Web of Science ®Google Scholar
• Sullivan PW, Ghushchyan VH, Globe G, Schatz M. Oral corticosteroid exposure and adverse effects in asthmatic patients. J Allergy Clin Immunol. 2018;141(1):110–116 e7. doi:10.1016/j.jaci.2017.04.009
   PubMed Web of Science ®Google Scholar
• Ekstrom M, Nwaru BI, Hasvold P, Wiklund F, Telg G, Janson C. Oral corticosteroid use, morbidity and mortality in asthma: a nationwide prospective cohort study in Sweden. Allergy. 2019;74(11):2181–2190. doi:10.1111/all.13874
   PubMed Web of Science ®Google Scholar
• Price DB, Trudo F, Voorham J, et al. Adverse outcomes from initiation of systemic corticosteroids for asthma: long-term observational study. J Asthma Allergy. 2018;11:193–204. doi:10.2147/JAA.S176026
   PubMed Web of Science ®Google Scholar
• Blakey J, Chung LP, McDonald VM, et al. Oral corticosteroids stewardship for asthma in adults and adolescents: a position paper from the Thoracic Society of Australia and New Zealand. Respirology. 2021;26(12):1112–1130. doi:10.1111/resp.14147
   PubMed Web of Science ®Google Scholar
• Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention, 2022 report; 2022. Available from: https://ginasthma.org/wp-content/uploads/2022/05/GINA-Main-Report-2022-FINAL-22-05-03-WMS.pdf. Accessed March 8, 2024.
   Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease 2021 report; 2021. Available from: https://goldcopd.org/wp-content/uploads/2020/11/GOLD-REPORT-2021-v1.1-25Nov20_WMV.pdf. Accessed March 8, 2024.
   Google Scholar
• Menzies-Gow A, Canonica GW, Winders TA, Correia de Sousa J, Upham JW, Fink-Wagner AH. A charter to improve patient care in severe asthma. Adv Ther. 2018;35(10):1485–1496. doi:10.1007/s12325-018-0777-y
   PubMed Web of Science ®Google Scholar
• Menzies-Gow A, Jackson DJ, Al-Ahmad M, et al. A renewed charter: key principles to improve patient care in severe asthma. Adv Ther. 2022;39(12):5307–5326. doi:10.1007/s12325-022-02340-w
   PubMed Web of Science ®Google Scholar
• Chhaya V, Saxena S, Cecil E, et al. Steroid dependency and trends in prescribing for inflammatory bowel disease - a 20-year national population-based study. Aliment Pharmacol Ther. 2016;44(5):482–494. doi:10.1111/apt.13700
   PubMed Web of Science ®Google Scholar
• Fardet L, Petersen I, Nazareth I. Prevalence of long-term oral glucocorticoid prescriptions in the UK over the past 20 years. Rheumatology. 2011;50(11):1982–1990. doi:10.1093/rheumatology/ker017
   PubMed Web of Science ®Google Scholar
• Taylor PC, Alten R, Reino JJG, et al. Factors influencing the use of biologic therapy and adoption of treat-to-target recommendations in current European rheumatology practice. Patient Prefer Adherence. 2018;12:2007–2014. doi:10.2147/PPA.S170054
   PubMed Web of Science ®Google Scholar
• Crowson LP, Davids JM, Hanson AC, et al. Time trends in glucocorticoid use in rheumatoid arthritis during the biologics era: 1999–2018. Semin Arthritis Rheum. 2023;61. doi:10.1016/j.semarthrit.2023.152219
   PubMed Web of Science ®Google Scholar
• Kariburyo F, Xie L, Sah J, Li N, Lofland JH. Real-world medication use and economic outcomes in incident systemic lupus erythematosus patients in the United States. J Med Econ. 2020;23(1):1–9. doi:10.1080/13696998.2019.1678170
   PubMed Web of Science ®Google Scholar
• Yates M, MacGregor AJ, Ledingham J, et al. Variation and implications of treatment decisions in early rheumatoid arthritis: results from a nationwide cohort study. Rheumatology. 2020;59(8):2035–2042. doi:10.1093/rheumatology/kez550
   PubMed Web of Science ®Google Scholar
• Tran TN, King E, Sarkar R, et al. Oral corticosteroid prescription patterns for asthma in France, Germany, Italy and the UK. Eur Respir J. 2020;55(6):1902363. doi:10.1183/13993003.02363-2019
   PubMed Web of Science ®Google Scholar
• Bénard-Laribière A, Pariente A, Pambrun E, Bégaud B, Fardet L, Noize P. Prevalence and prescription patterns of oral glucocorticoids in adults: a retrospective cross-sectional and cohort analysis in France. BMJ Open. 2017;7(7):e015905. doi:10.1136/bmjopen-2017-015905
   PubMed Web of Science ®Google Scholar
• OPCRD optimum patient care research database; 2022. Available from: https://opcrd.co.uk/about-opcrd/our-team/. Accessed July 8, 2022.
   Google Scholar
• Busse WW, Kraft M, Rabe KF, et al. Understanding the key issues in the treatment of uncontrolled persistent asthma with type 2 inflammation. Eur Respir J. 2021;58(2):2003393. doi:10.1183/13993003.03393-2020
   PubMed Web of Science ®Google Scholar
• Bel EH, Wenzel SE, Thompson PJ, et al. Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma. N Engl J Med. 2014;371(13):1189–1197. doi:10.1056/NEJMoa1403291
   PubMed Web of Science ®Google Scholar
• Nair P, Wenzel S, Rabe KF, et al. Oral glucocorticoid-sparing effect of benralizumab in severe asthma. N Engl J Med. 2017;376(25):2448–2458. doi:10.1056/NEJMoa1703501
   PubMed Web of Science ®Google Scholar
• Fan VS, Gaziano JM, Lew R, et al. A comprehensive care management program to prevent chronic obstructive pulmonary disease hospitalizations: a randomized, controlled trial. Ann Intern Med. 2012;156(10):673–683. doi:10.7326/0003-4819-156-10-201205150-00003
   PubMed Web of Science ®Google Scholar
• Farias R, Sedeno M, Beaucage D, et al. Innovating the treatment of COPD exacerbations: a phone interactive telesystem to increase COPD action plan adherence. BMJ Open Respir Res. 2019;6(1):e000379. doi:10.1136/bmjresp-2018-000379
   PubMed Web of Science ®Google Scholar
• Bardhan KD, Simmonds N, Royston C, Dhar A, Edwards CM, Rotherham IBDDUG. A United Kingdom inflammatory bowel disease database: making the efFort worthwhile. J Crohns Colitis. 2010;4(4):405–412. doi:10.1016/j.crohns.2010.01.003
   PubMed Web of Science ®Google Scholar
• Jenkinson PW, Plevris N, Siakavellas S, et al. Temporal trends in surgical resection rates and biologic prescribing in Crohn’s disease: a population-based cohort study. J Crohns Colitis. 2020;14(9):1241–1247. doi:10.1093/ecco-jcc/jjaa044
   PubMed Web of Science ®Google Scholar
• Selinger CP, Parkes GC, Bassi A, et al. Assessment of steroid use as a key performance indicator in inflammatory bowel disease-analysis of data from 2385 UK patients. Aliment Pharmacol Ther. 2019;50(9):1009–1018. doi:10.1111/apt.15497
   PubMed Web of Science ®Google Scholar
• Rossetti S, Actis GC, Fadda M, Rizzetto M, Palmo A. The use of the anti-tumour necrosis factor monoclonal antibody--infliximab--to treat ulcerative colitis: implications and trends beyond the available data. Dig Liver Dis. 2004;36(6):426–431. doi:10.1016/S1590-8658(04)00088-X
   PubMedGoogle Scholar
• Ljung T, Karlen P, Schmidt D, et al. Infliximab in inflammatory bowel disease: clinical outcome in a population based cohort from Stockholm County. Gut. 2004;53(6):849–853. doi:10.1136/gut.2003.018515
   PubMed Web of Science ®Google Scholar
• Selinger CP, Parkes GC, Bassi A, et al. A multi-centre audit of excess steroid use in 1176 patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2017;46(10):964–973. doi:10.1111/apt.14334
   PubMed Web of Science ®Google Scholar
• Kalo Z, Voko Z, Ostor A, et al. Patient access to reimbursed biological disease-modifying antirheumatic drugs in the European region. J Mark Access Health Policy. 2017;5(1):1345580. doi:10.1080/20016689.2017.1345580
   PubMedGoogle Scholar
• National Health Service. Quality and outcomes framework. NHS. Available from: https://digital.nhs.uk/data-and-information/data-collections-and-data-sets/data-collections/quality-and-outcomes-framework-qof. Accessed October 19, 2020.
   Google Scholar
• Suehs CM, Menzies-Gow A, Price D, et al. Expert consensus on the tapering of oral corticosteroids for the treatment of asthma. A Delphi study. Am J Respir Crit Care Med. 2021;203(7):871–881. doi:10.1164/rccm.202007-2721OC
   PubMed Web of Science ®Google Scholar